Neural Network Startups Proliferate Across The U.S.

Creating machines that truly mimic the mind has long been the Holy Grail of computer scientists. And like the path to that mythical prize, the quest for artificial “brains” that can balance a checkbook or recognize flaws in aircraft engines with all the aplomb of a human is strewn with failed attempts But now there is a promising new contender. The approach goes by the name artificial neural network, because it works by duplicating the neural structure of the brain and it is already

Written byColin Johnson
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Creating machines that truly mimic the mind has long been the Holy Grail of computer scientists. And like the path to that mythical prize, the quest for artificial “brains” that can balance a checkbook or recognize flaws in aircraft engines with all the aplomb of a human is strewn with failed attempts But now there is a promising new contender. The approach goes by the name artificial neural network, because it works by duplicating the neural structure of the brain and it is already proving its mettle in perhaps the sternest test of all—the cutthroat competition for investment capital.

A new wave of entrepreneurs anxious to turn the fledgling science into profitable products is on the scene, and dozens of small startup companies are springing up across the country (see chart page 7). Already it is possible to buy neural net programs that predict the movement of the Standard & ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies